SCHEMBL23770826

SCHEMBL23770826

COc1ccc(F)cc1-c1nc(NSc2cccc(N3CCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.41
LRRK2 Q5S007 3/20 0.39
GALR2 O43603 2/20 0.38
GALR1 P47211 2/20 0.38
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE4B Q07343 1/20 0.34
ATR Q13535 1/20 0.33
ATRIP Q8WXE1 1/20 0.33
PPARG P37231 1/20 0.33
RORC P51449 1/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
ITGB2 P05107 1/20 0.33
ICAM1 P05362 1/20 0.33
ITGAL P20701 1/20 0.33
MAP4K1 Q92918 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770765 0.92 S1PR1 (0.35) S1PR1LRRK2GALR2GALR1ALDH1A1
SCHEMBL23770452 0.86 PDE10A (0.34) S1PR1GALR2GALR1KDM4EMAPT
SCHEMBL23770466 0.82 CYP1A2 (0.37) ALDH1A1KDM4ECDK2
SCHEMBL23770770 0.81 ADRB2 (0.38) ALDH1A1
SCHEMBL23770671 0.80 GALR2 (0.39) GALR2GALR1ALDH1A1HPGDKDM4E
SCHEMBL23770739 0.79 CNR2 (0.38) GALR2GALR1MAPK1
SCHEMBL23770632 0.79 ADRB2 (0.42) ALDH1A1
SCHEMBL23770433 0.79 PDE10A (0.36) GALR2GALR1ALDH1A1KDM4EL3MBTL1
SCHEMBL23770694 0.79 GALR2 (0.40) GALR2GALR1ALDH1A1KDM4E
SCHEMBL23770664 0.78 NPY5R (0.36) GALR2GALR1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed